Literature DB >> 12325059

A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.

A Eustace1, R Coen, C Walsh, C J Cunningham, J B Walsh, D Coakley, B A Lawlor.   

Abstract

BACKGROUND: Non-cognitive symptoms are a frequent feature of Alzheimer's disease (AD). Much of the literature that has accumulated pertains to cross-sectional prevalence of these symptoms. There has been relatively little attention paid to the longitudinal course of Behavioural and Psychological Symptoms of Dementia (BPSD). AIMS: The purpose of this study is to examine the longitudinal course of BPSD in a group of patients with mild AD.
METHODS: A retrospective review of a database was performed to identify patients with NINCDS/ADRDA criteria for probable AD and who had been evaluated three times at yearly interval over a two-year period. Fifty-two subjects were identified with probable AD that had completed follow-up for 24 months. The BEHAVE-AD was used to evaluate BPSD and data was analysed using a Markov analysis.
RESULTS: Activity disturbance is a common and relatively persistent symptom in the mild stages of AD. Anxiety, paranoid ideation, and aggression were moderately persistent. Affective symptoms were not persistent with less than half the patients having the symptoms a year later.
CONCLUSIONS: Activity disturbance is common and persistent in early AD. Paranoid and delusional ideation shows moderate persistence and depressive symptoms infrequently last longer than a year. These findings may have clinical relevance for the pharmacological and non-pharmacological management of BPSD. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325059     DOI: 10.1002/gps.736

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  17 in total

1.  Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).

Authors:  Nathan Herrmann; Tetsuhiro Harimoto; Robert Balshaw; Krista L Lanctôt
Journal:  Can J Psychiatry       Date:  2015-04       Impact factor: 4.356

2.  Nonpharmacologic management of behavioral symptoms in dementia.

Authors:  Laura N Gitlin; Helen C Kales; Constantine G Lyketsos
Journal:  JAMA       Date:  2012-11-21       Impact factor: 56.272

3.  3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.

Authors:  Elaine K Hebda-Bauer; Tracy A Simmons; Andrew Sugg; Eren Ural; James A Stewart; James L Beals; Qiang Wei; Stanley J Watson; Huda Akil
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Anxiety and stigma in dementia: a threat to aging in place.

Authors:  Rebecca J Riley; Sandy Burgener; Kathleen C Buckwalter
Journal:  Nurs Clin North Am       Date:  2014-06       Impact factor: 1.208

5.  "Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis.

Authors:  Mary Clare Masters; John C Morris; Catherine M Roe
Journal:  Neurology       Date:  2015-02-10       Impact factor: 9.910

6.  The prototypical ranitidine analog JWS-USC-75-IX improves information processing and cognitive function in animal models.

Authors:  Alvin V Terry; Jerry J Buccafusco; Elizabeth J Herman; Patrick M Callahan; Wayne D Beck; Samantha Warner; Leah Vandenhuerk; Kristy Bouchard; Gary M Schwarz; Jie Gao; James M Chapman
Journal:  J Pharmacol Exp Ther       Date:  2010-11-24       Impact factor: 4.030

7.  Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort.

Authors:  S Gonfrier; S Andrieu; D Renaud; B Vellas; P H Robert
Journal:  J Nutr Health Aging       Date:  2012-02       Impact factor: 4.075

8.  Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria.

Authors:  Edmond Teng; John M Ringman; Leslie K Ross; Ruth A Mulnard; Malcolm B Dick; George Bartzokis; Helen D Davies; Douglas Galasko; Linda Hewett; Dan Mungas; Bruce R Reed; Lon S Schneider; Freddi Segal-Gidan; Kristine Yaffe; Jeffrey L Cummings
Journal:  Am J Geriatr Psychiatry       Date:  2008-06       Impact factor: 4.105

Review 9.  Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.

Authors:  Dapinder Kaur; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Simona Bungau
Journal:  Neurochem Res       Date:  2021-08-06       Impact factor: 3.996

10.  Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD).

Authors:  Rosa Liperoti; Claudio Pedone; Andrea Corsonello
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.